TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8775106

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 500

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 500
Study: 1619587

Group type: EXPERIMENTAL
Intervention: Contingent heart rate biofeedback
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Non-contingent feedback (decreased heart rate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Competition mentioned
Number of subjects: 32

Group type: COMPARATOR
Intervention: No competitive instructions
Number of subjects: 32
Study: 6377492

Group type: EXPERIMENTAL
Intervention: Indotard 50 mg given twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indocid 25 mg given four times daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Indotard (younger patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indocid (older patients)
Number of subjects: 30
Study: 31364474

Group type: EXPERIMENTAL
Intervention: Telehealth+SMS
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Telehealth
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 44
Study: 30016391

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by concurrent chemoradiotherapy (I-CCRT)
Number of subjects: 479

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 479
Study: 27297843

Group type: EXPERIMENTAL
Intervention: Ticagrelor without GPI
Number of subjects: 19824

Group type: EXPERIMENTAL
Intervention: Ticagrelor with GPI
Number of subjects: 19824

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 19824
Study: 25101534

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - 10 sessions, 830 nm, 50 mW output power, 707 J/cm² fluence; L group, n=23
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo treatment - 10 sessions; P group, n=20
Number of subjects: 43
Study: 23350191

Group type: EXPERIMENTAL
Intervention: Ergoferon
Number of subjects: 213

Group type: COMPARATOR
Intervention: Oseltamivir (150 mg daily for 5 days)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 213
Study: 20507198

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (home televisits with nurse and dietitian educators every 4‐6 weeks for 2‐6 years)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (home televisits)
Number of subjects: 610
Study: 18656868

Group type: EXPERIMENTAL
Intervention: Harris Hip Score
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Barthel Index
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Eq‐5d index score
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Eq‐5d visual analogue scale
Number of subjects: 222
Study: 15918196

Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: esomeprazole 20 mg
Number of subjects: 134
Study: 12514155

Group type: EXPERIMENTAL
Intervention: LMA‐Classic (LMA‐C) or LMA‐ProSeal (PLMA)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: LMA‐C or PLMA
Number of subjects: 209

Group type: COMPARATOR
Intervention: ETT
Number of subjects: 209
Study: 12145072

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg initial loading dose for 10 min; maintenance, 0.4‐0.7 microg. kg(‐1). h(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol (75 microg. kg(‐1). min(‐1) x 10 min; maintenance, 12.5‐75 microg. kg(‐1). min(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study: 10335872

Group type: EXPERIMENTAL
Intervention: SCF plus filgrastim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filgrastim alone
Number of subjects: 0
Study: 7780060

Group type: EXPERIMENTAL
Intervention: High-flux polysulphone membranes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-flux cellulose-based membranes
Number of subjects: 0
Study: 2081012

Group type: EXPERIMENTAL
Intervention: Informed group (received letter about high blood pressure)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (received neutral letter)
Number of subjects: 29
Study: 6988174

Group type: EXPERIMENTAL
Intervention: Ciramadol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31888939

Group type: EXPERIMENTAL
Intervention: TAU + app + web
Number of subjects: 250

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 250
Study: 26641648

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6 μg/kg/h)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (0.9% sodium chloride)
Number of subjects: 150
Study: 26402337

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 24045792

Group type: EXPERIMENTAL
Intervention: Dietary counseling advocating choice of foods to increase unsaturated FA intake and reduce saturated FA intake.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no dietary counseling).
Number of subjects: 90
Study: 21159327

Group type: EXPERIMENTAL
Intervention: Verbal worry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagery-based worry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (low-worriers)
Number of subjects: 0
Study: 19433392

Group type: EXPERIMENTAL
Intervention: Endocrine therapy for breast cancer
Number of subjects: 251
Study: 18028772

Group type: EXPERIMENTAL
Intervention: Carbon fiber dressing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Silver nanoparticle dressing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hydrogel dressing
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vaseline gauze
Number of subjects: 120
Study: 14998841

Group type: EXPERIMENTAL
Intervention: SuperMIP (mitomycin C 6 mg/m2; ifosfamide 4.5 g/m2; cisplatin 60 mg/m2; carboplatine 200 mg/m2)
Number of subjects: 351

Group type: COMPARATOR
Intervention: MIP (mitomycin C 6 mg/m2; ifosfamide 3 g/m2; cisplatin 50 mg/m2)
Number of subjects: 351

Group type: COMPARATOR
Intervention: MIP
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: SuperMIP
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: MIP and SuperMIP
Number of subjects: 351
Study: 11489064

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide plus bumetanide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9721778

Group type: EXPERIMENTAL
Intervention: PGE2 vaginal suppositories alone
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: PGE2 plus Laminaria
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: PGE2 plus Laminaria plus gel
Number of subjects: 175
Study: 8151058

Group type: EXPERIMENTAL
Intervention: Active treatment with 13.2 micrograms Fel d I antigen
Number of subjects: 28
Study: 3049213

Group type: EXPERIMENTAL
Intervention: 400 mg of nitrofurantoin
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 400 mg of furazolidone
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 31549416

Group type: EXPERIMENTAL
Intervention: Ball attachment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Equator attachment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both attachments
Number of subjects: 18

Group type: COMPARATOR
Intervention: Patient preference for retention system
Number of subjects: 18
Study: 27560256

Group type: EXPERIMENTAL
Intervention: Nutrition education program (5 education sessions over 7 months)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 57
Study: 27755543

Group type: EXPERIMENTAL
Intervention: Uncontrolled abnormal glucose metabolism (AGM) among pre-diagnosed diabetic cases
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Age increase by one year
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Retired status
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Overweight status
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ex-drinker status
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Hypertension (Stage I)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Hypertension (Stage II)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Unemployed status
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Business-owner status
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ex-smoker status
Number of subjects: 269
Study: 25447748

Group type: EXPERIMENTAL
Intervention: Thermal cure (spa treatment including underwater shower, massage-jet showers, hydromassage, pool rehabilitation, and peloid therapy)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Non-thermal rehabilitation (analgesic physiotherapy, muscle strengthening, and group physical rehabilitation)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Comparison at day 21
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Comparison at 12 months
Number of subjects: 240
Study: 22077475

Group type: EXPERIMENTAL
Intervention: Stressful life events
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mental stressors
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Physical stressors
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Stress severity
Number of subjects: 160
Study: 20408861

Group type: EXPERIMENTAL
Intervention: Oral NTHi treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 64
Study: 18202420

Group type: EXPERIMENTAL
Intervention: Urokinase rinses (5 mL of 5,000 U/mL) three times weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline) three times weekly
Number of subjects: 0
Study: 16578941

Group type: EXPERIMENTAL
Intervention: Distant, intercessory prayer
Number of subjects: 15
Study: 15215700

Group type: EXPERIMENTAL
Intervention: Douching after menses
Number of subjects: 250
Study: 11056121

Group type: EXPERIMENTAL
Intervention: Stop protocol (GnRHa administration stopped with the onset of menses, high doses of gonadotrophins)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-stop protocol (long GnRHa suppression with high doses of gonadotrophins)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Stop protocol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-stop protocol
Number of subjects: 70
Study: 8937948

Group type: EXPERIMENTAL
Intervention: Academic detailing (AD) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AD plus Continuous Quality Improvement (CQI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12
Study: 1546821

Group type: EXPERIMENTAL
Intervention: MDI only
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: MDI with spacer
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 123

Group type: COMPARATOR
Intervention: MDI with spacer and Turbuhaler
Number of subjects: 123
Study: 3987071

Group type: EXPERIMENTAL
Intervention: Naloxone (15 mg infusion)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fenfluramine (60 mg orally)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Naloxone (30 mg infusion)
Number of subjects: 7
Study: 2906946

Group type: EXPERIMENTAL
Intervention: Relaxation training and imaginal exposure to vitamin consumption followed by in vivo exposure to vitamin taking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo exposure to aspirin and placebo capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalization of treatment effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up assessments at three and six months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychophysiological assessment data
Number of subjects: 0
Study: 30418164

Group type: EXPERIMENTAL
Intervention: Synergy DES
Number of subjects: 24
Study: 28697117

Group type: EXPERIMENTAL
Intervention: Video colposcopy
Number of subjects: 225

Group type: COMPARATOR
Intervention: No video colposcopy
Number of subjects: 225
Study: 26153198

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle intervention package at baseline and three months
Number of subjects: 640
Study: 22773233

Group type: EXPERIMENTAL
Intervention: Titanium-coated lightweight mesh
Number of subjects: 102

Group type: COMPARATOR
Intervention: Medium-weight composite mesh
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study: 21210608

Group type: EXPERIMENTAL
Intervention: Hybrid clinical experiences (part simulation and part traditional clinical)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional clinical experiences
Number of subjects: 0
Study: 19229804

Group type: EXPERIMENTAL
Intervention: Mechanical compression therapy followed by a compression bandage (302 patients, group 1)
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Manual compression with application of a calcium ion releasing device (303 patients; group 2)
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Manual compression with a thrombin covered PAD without compression bandage (303 patients, group 3)
Number of subjects: 908
Study: 16498158

Group type: EXPERIMENTAL
Intervention: Atropine (0.01 mg/kg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 11753130

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management (phytotherapy, alpha‐blockers, 5 alpha‐reductase inhibitors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 0
Study: 10091954

Group type: EXPERIMENTAL
Intervention: Acamprosate 2 g daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7575861

Group type: EXPERIMENTAL
Intervention: Antenatal and postnatal support groups
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study: 15374489

Group type: EXPERIMENTAL
Intervention: 30 mg nicergoline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 60 mg nicergoline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5 mg co-dergocrine mesylate (CDM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 12
Study: 37863

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg i.v.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diazepam 10 mg i.v.
Number of subjects: 90
Study: 31755550

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: DASH diet counseling
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combined AE + DASH
Number of subjects: 160

Group type: COMPARATOR
Intervention: Health education (HE) controls
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-exercise groups
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-DASH participants
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-Exercise participants
Number of subjects: 160
Study: 30290018

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.33% gel once a day for 4 days
Number of subjects: 37
Study: 27527199

Group type: EXPERIMENTAL
Intervention: Social interactions about e-cigarettes
Number of subjects: 2149

Group type: EXPERIMENTAL
Intervention: Recommendations to use e-cigarettes
Number of subjects: 2149

Group type: EXPERIMENTAL
Intervention: Reasons for recommending e-cigarettes
Number of subjects: 2149

Group type: EXPERIMENTAL
Intervention: Factors associated with recommending e-cigarettes for health reasons
Number of subjects: 2149
Study: 24164733

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 177

Group type: COMPARATOR
Intervention: Galantamine
Number of subjects: 177
Study: 24321716

Group type: EXPERIMENTAL
Intervention: Combined and resistance exercise
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 28
Study: 20966319

Group type: EXPERIMENTAL
Intervention: Dilute iohexol (Omnipaque)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Dilute diatrizoate sodium (Gastroview)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 300
Study: 18212336

Group type: EXPERIMENTAL
Intervention: Intervention challenging the legitimacy of the sociocultural norm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 16573705

Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg once daily
Number of subjects: 1974

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1974
Study: 14602740

Group type: EXPERIMENTAL
Intervention: Troglitazone (TGZ) 150 mg/d
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Troglitazone (TGZ) 300 mg/d
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Troglitazone (TGZ) 600 mg/d
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 398
Study: 10849246

Group type: EXPERIMENTAL
Intervention: Naso-oesophageal probe
Number of subjects: 35
Study: 8785074

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 104

Group type: COMPARATOR
Intervention: Open hernia repair
Number of subjects: 104
Study: 1860284

Group type: EXPERIMENTAL
Intervention: Metronidazole (3 times daily for 7 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (3 times daily for 7 days)
Number of subjects: 10
Study: 6802408

Group type: EXPERIMENTAL
Intervention: Verapamil (120 mg single oral dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30583953

Group type: EXPERIMENTAL
Intervention: Reliable mixed H∞ and passive control under adaptive event-triggered scheme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive event-triggered scheme
Number of subjects: 0
Study: 29394491

Group type: EXPERIMENTAL
Intervention: l-citrulline (6 g/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study: 27244859

Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P)
Number of subjects: 3147

Group type: COMPARATOR
Intervention: Quality Improvement Technical Support (QITS)
Number of subjects: 3147
Study: 24969056

Group type: EXPERIMENTAL
Intervention: Rifaximin (200 mg, 2 tablets bid, for 7 days monthly for 12 months) and probiotic VSL#3 (450 × 10(9) FU per day)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Rifaximin and VSL#3
Number of subjects: 106

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 106
Study: 22574799

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy (DBT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 42
Study: 21062838

Group type: EXPERIMENTAL
Intervention: HEIA intervention programme (12 schools)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (25 schools)
Number of subjects: 114
Study: 18674402

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 79
Study: 15831901

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 12856483

Group type: EXPERIMENTAL
Intervention: Increased digoxin synthesis, decreased membrane Na(+)‐K+ ATPase activity, increased tryptophan catabolites (serotonin, quinolinic acid, and nicotine), decreased tyrosine catabolites (dopamine, noradrenaline, and morphine) in creative individuals; correlated with right hemispheric dominance.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decreased digoxin synthesis, increased membrane Na(+)‐K+ ATPase activity, decreased tryptophan catabolites (serotonin, quinolinic acid, and nicotine), increased tyrosine catabolites (dopamine, noradrenaline, and morphine) in non-creative individuals; correlated with left hemispheric dominance.
Number of subjects: 0
Study: 10680108

Group type: EXPERIMENTAL
Intervention: Group A (LMA removed when signs of rejection observed)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Group B (LMA removed when patient could open mouth on command)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 8988452

Group type: EXPERIMENTAL
Intervention: Trazodone 100 mg/day + Pindolol 7.5 mg/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Trazodone 100 mg/day + Fluoxetine 20 mg/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Trazodone 100 mg/day + Placebo
Number of subjects: 33
Study: 1361935

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6439565

Group type: EXPERIMENTAL
Intervention: Intranasal disodium chromoglycate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31932571

Group type: EXPERIMENTAL
Intervention: Social skills development program based on Gardner's Multiple Intelligence Theory
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 67
Study: 29156378

Group type: EXPERIMENTAL
Intervention: Robotic-assisted gait training therapy using Lokomat®Pediatric, 20 sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (no sessions of Lokomat®Pediatric)
Number of subjects: 30
Study: 26399905

Group type: EXPERIMENTAL
Intervention: Assistive approach presenting calculated risks of postoperative nausea and vomiting (PONV) to physicians.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Not applicable (control group not explicitly mentioned).
Number of subjects: 57
Study: 24201706

Group type: EXPERIMENTAL
Intervention: 10,000 steps/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1,500 steps/day
Number of subjects: 0
Study: 23144467

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 216
Study: 20229018

Group type: EXPERIMENTAL
Intervention: Hypoxic intervention (75 min at simulated altitude of 2,980 m)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control values (trial day one)
Number of subjects: 12